No background science here or lengthy explanations, only 15 easy guidelines to follow to kick-start your Paleo journey. It’s up to you to decide to what extent you want to follow those guidelines, but if you follow them 100% you can be assured that you are eating the best food for your body and greatly investing in your long term health and well-being.
The Great Cholesterol Con: The Truth About What Really Causes Heart Disease and How to Avoid It by Dr. Malcolm Kendrick reveals that high cholesterol levels do not cause heart disease; that high-fat diets–saturated or otherwise–do not affect blood cholesterol levels; and that for most men and all women the benefits offered by statins are negligible at best. Other data is also provided that shows that statins have many more side affects than is often acknowledged.
I was so happy to find your whole30 menu, this is the first time on this plan and mid week 2 I was at a loss of what to eat. I am great at counting carbs but this is all new and couldn’t use my old standby meals. MY reason for doing this is I want to get the fake sugars out of my daily life and this was a great way to jump start this for me. meal planning is a lot of work and thank you
is something you have to experience to truly understand and appreciate. CFHP is a fitness community of committed and focused individuals who are determined, dedicated and constantly setting and achieving new goals. Our brand new state of the art facility has no fancy equipment or machinery; just the basic tools of a true training program that delivers proven, measurable results.
Next, check out my gal Holly’s post about the process of reintroducing foods after completing a Whole30. As she reminds us, it’s important not to just go crazy on Day 31. Instead, “[e]xperiment with foods you miss, but do it in a way that will actually help you gather more information.” The Whole30 website also has a great post on what to do when your Whole30 is finished here.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”